UA Study on Flu Evolution May Change Textbooks, History Books
A new study reconstructing the evolutionary tree of flu viruses challenges conventional wisdom and solves some of the mysteries surrounding flu outbreaks of historical significance
Of mice and men: fine-tuning salmonella-based vaccines
An innovative vaccine technology makes use of reengineered salmonella to deliver protective immunity. If such recombinant attenuated salmonella vaccines, or RASVs, can be perfected, they hold the promise of safe, low-cost, orally-administered defenses against viral, bacterial, fungal and parasitic infections.Continue reading
UA scientist pushes new uses for DNA tests
TGen and Mayo Clinic researchers use genomic sequencing to help identify new therapies for bile duct cancer
Study targets EGFR and FGFR cellular pathways to treat rare diseaseContinue reading
HTG Molecular Diagnostics Completes Initial Series E Preferred Stock Offering
TUCSON, AZ, Feb 11, 2014 (Media Release) — HTG Molecular Diagnostics (“HTG”) today announced the initial closing of its Series E offering with existing investors Novo Ventures, SROne, Merck Capital Ventures, and Fletcher Spaght. Proceeds will support commercial and product development initiatives.Continue reading
TGen study uncovers possible genetic markers in breast cancer that spreads to the brain
New treatments might be possible for patients who now have little hopeContinue reading
Mathematical Model Developed by UA Physicists Could Help Treat Lyme Disease
A computer simulation of Lyme disease rash might help doctors better predict the spread of the bacteria in the early stages when antibiotics are most effective.
By University Communications, February 6, 2014Continue reading
NuvOx Makes the Transition from the Laboratory to the Clinic and is Pounding the Pavement to Raise $15MM.
NuvOx Pharma, a Tucson-based biotech startup, founded in 2008 is metamorphosing from an R&D startup to one that is testing the Company’s nanotechnology therapeutic platform in the clinic.Continue reading